We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blocking RON Shuts Down Breast Cancer Metastasis

By LabMedica International staff writers
Posted on 16 Jan 2014
Print article
A recent paper suggested that initiation of breast cancer metastasis did not depend on a specific genetic mutation but rather on improper regulation of molecular pathways that control activation and inactivation of certain critical genes.

Investigators at the University of Utah (Salt Lake City, USA) focused their research on the protein product of the RON gene, known as macrophage stimulating 1-receptor (MST1R), a member of the Met family of receptor tyrosine kinases. The biological activity of RON was mediated by binding of its extracellular ligand, macrophage-stimulating protein (MSP), and the protein macrophage stimulating 1 (MST1). Binding of MSP activated RON and led to cellular growth, motility, and invasion. Recent studies have documented RON overexpression in a variety of human cancers including those of the breast, colon, liver, pancreas, and bladder, which often correlate with poor outcome. Moreover, clinical studies have shown that RON overexpression is associated with metastasis and worse patient outcomes.

In the current study, published in the January 2, 2014, online edition of the journal Cell Reports, the investigators showed that the RON/MSP pathway enhanced metastasis of breast cancer xenografts by reprogramming DNA methylation at specific target genes.

RON/MSP-initiated differential-DNA methylation was found to be the result of upregulation of the enzyme MBD4 (methyl-CpG binding domain protein 4), a thymine DNA glycosylase. MBD4 bound specifically to methylated DNA via an MBD domain at the N-terminus that functioned both in binding to methylated DNA and in protein interactions and a C-terminal mismatch-specific glycosylase domain that was involved in DNA repair.

Knockdown of MBD4 in RON/MSP-expressing breast cancer cells or inhibition of the glycosylase catalytic residue of MBD4 reversed the DNA methylation pattern on specific loci and blocked metastasis.

“Genetic mutations do not drive this mechanism,” said senior author Dr. Alana Welm, associate professor of oncological sciences at the University of Utah. “Instead, it is improper regulation of when genes turn on and off. No one has ever described a specific pathway driving this kind of reprogramming in metastasis, much less a way to therapeutically block it. Also, RON has not previously been known to be involved in reprogramming gene expression.”

“If there is an entire program in the tumor cell that is important for metastasis, blocking one small part of that program, for example, the action of a single gene will probably not be an effective strategy,” said Dr. Welm. “But if you could find a way to turn off the entire program, you are more likely to have the desired effect. We found that inhibiting RON turns off the entire metastasis program in these tumor cells.

Related Links:

University of Utah


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.